Kabbinavar, Fairooz
Cardiff Oncology Inc.,
United States
2024 Rank: 125606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4790 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125606 | 145794 |
| Total Cites | 29510 | 30696 |
| H-index | 56 | 57 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 3358 | 3447 |
| Number of Single+First+Last Authored Papers | 28 | 28 |
| Total Cites to Single+First+Last Authored Papers | 15530 | 15867 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 23526 | 24326 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.26 |
| Self-Citation Percentage |
3.86%
|
|
Kabbinavar, Fairooz
Ronald Reagan UCLA Medical Center,
United States
2022 Rank: 113324
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4413 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113324 | 130057 |
| Total Cites | 25952 | 27000 |
| H-index | 51 | 54 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 3227 | 3309 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 14711 | 15036 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20389 | 21103 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.28 |
| Self-Citation Percentage |
3.88%
|
|
Kabbinavar, Fairooz
Puma Biotechnology, Inc.,
United States
2021 Rank: 106440
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4178 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106440 | 121760 |
| Total Cites | 25085 | 26158 |
| H-index | 51 | 54 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 3165 | 3245 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 14409 | 14731 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19577 | 20294 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.29 |
| Self-Citation Percentage |
4.10%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.